WVPA Sharing

WVU researcher prototypes new equipment to improve head and neck cancer treatment

WVUToday Head and neck cancer may not be as common as breast or prostate cancer, but it’s one of the most challenging to treat. Its five-year survival rate can be as low as 25%, while its recurrence rate can be as high as 43%. West Virginia U
Already a subscriber? Log in here.

This story is free for you

Create a free account and get more of the Herald Record's top stories directly to your inbox.

Or, subscribe for unlimited access